NovoCure Ltd - Common Stock (NVCR)

Historical Holders from Q4 2015 to Q3 2025

Symbol
NVCR on Nasdaq
Type / Class
Equity / Common Stock
Shares outstanding
111,111,111
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
91,742,662
Holdings value
$1,185,376,041
% of all portfolios
0.002%
Number of holders
242
Number of buys
130
Number of sells
-122
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of NovoCure Ltd - Common Stock (NVCR)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Soleus Capital Master Fund, L.P. 8.6% +40% $124,611,746 +$35,408,164 9,644,872 +39.7% Soleus Capital Master Fund, L.P. 30 Sep 2025
BlackRock, Inc. 8.3% $161,870,108 9,083,620 BlackRock, Inc. 31 Mar 2025
Capital World Investors 1.8% -65% $25,840,000 -$56,626,396 2,000,000 -68.7% Capital World Investors 30 Sep 2025

Institutional Holders of NovoCure Ltd - Common Stock (NVCR)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 91,742,662 $1,185,376,041 -$65,862,677 $12.92 242
2025 Q2 94,465,807 $1,681,500,579 -$12,863,877 $17.8 238
2025 Q1 95,188,552 $1,696,317,393 +$20,032,634 $17.82 224
2024 Q4 91,569,880 $2,728,867,320 -$6,541,149 $29.8 236
2024 Q3 92,870,656 $1,451,669,248 -$11,382,332 $15.63 220
2024 Q2 92,921,141 $1,591,749,696 +$79,832,472 $17.13 229
2024 Q1 89,139,107 $1,393,245,089 -$23,081,055 $15.63 230
2023 Q4 263,509 $3,934,189 +$1,016,833 $14.93 2
2023 Q3 91,152,820 $1,472,210,430 -$63,470,630 $16.15 215
2023 Q2 89,184,203 $3,700,762,826 -$22,361,797 $41.5 250
2023 Q1 89,328,322 $5,371,952,456 +$289,192,883 $60.14 285
2022 Q4 83,909,168 $6,154,095,452 -$12,964,425 $73.35 286
2022 Q3 83,034,095 $6,308,626,498 +$222,918,594 $75.98 284
2022 Q2 80,007,908 $5,562,070,253 -$38,817,221 $69.5 284
2022 Q1 81,072,356 $6,715,614,583 +$237,687,782 $82.85 287
2021 Q4 78,107,259 $5,865,418,904 +$31,090,849 $75.08 284
2021 Q3 77,470,460 $9,001,574,774 -$79,617,117 $116.17 300
2021 Q2 77,554,176 $17,199,877,909 +$681,700,760 $221.82 350
2021 Q1 73,017,312 $9,650,187,440 +$117,823,846 $132.18 313
2020 Q4 74,154,111 $12,831,266,583 +$246,783,732 $173.04 344
2020 Q3 73,023,087 $8,126,468,764 +$543,592,499 $111.31 265
2020 Q2 69,087,104 $4,096,032,751 -$79,710,864 $59.3 254
2020 Q1 70,226,112 $4,727,523,890 +$67,830,767 $67.34 255
2019 Q4 69,039,641 $5,817,841,762 +$164,149,700 $84.27 251
2019 Q3 66,669,222 $4,985,153,900 +$91,849,435 $74.78 230
2019 Q2 65,731,469 $4,154,391,517 +$248,300,371 $63.23 186
2019 Q1 63,492,417 $3,058,372,144 +$301,569,077 $48.17 193
2018 Q4 57,296,941 $1,918,258,944 +$53,711,292 $33.48 161
2018 Q3 54,686,033 $2,865,566,092 +$201,344,784 $52.4 172
2018 Q2 51,787,766 $1,620,948,332 +$282,902,138 $31.3 158
2018 Q1 44,008,201 $959,279,211 +$148,499,824 $21.8 131
2017 Q4 37,382,594 $755,132,400 +$13,375,574 $20.2 122
2017 Q3 36,811,567 $730,751,052 +$98,792,888 $19.85 101
2017 Q2 31,870,536 $551,351,062 +$204,323,240 $17.3 81
2017 Q1 20,220,121 $164,019,561 +$27,081,551 $8.1 66
2016 Q4 20,111,055 $157,862,948 +$10,123,034 $7.85 72
2016 Q3 18,826,075 $160,712,151 -$21,761,604 $8.54 61
2016 Q2 19,159,363 $223,585,591 +$67,245,761 $11.67 63
2016 Q1 13,609,704 $196,872,145 +$32,309,931 $14.48 55
2015 Q4 11,312,689 $249,219,971 +$248,825,091 $22.36 47